What would you ask an entrepreneur who’s led multiple biotechs from founding to multi-million dollar exits? Enjoy your morning coffee while hearing from Mike Gilman, currently CEO and Chairman of Arrakis, a Boston based company developing small molecules to drug RNA (and just closed a $75M series B!) Mike was previously founder and CEO of Padlock Therapeutics, an autoimmune disease focused company with a presence in San Diego, which was acquired in 2016 with a deal of up to $600M. He also recently worked at Biogen Idec, after it acquired Stromedix – where he was founder and CEO – in a deal of up to $562M. Don’t miss Mike’s visit to San Diego to share his stories and insights with the innovation community.